Search research articles
Contact Us
Filters
Showing results (81-90 of 135) with videos related to
Page
of 14
Sort By:
Stem Cell Research & Therapy
|
January 25, 2014
Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis
Kyle D Fink, Julien Rossignol, Andrew T Crane, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 8, 2019
Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS
Richard Lemal, Guillemette Fouquet, Louis Terriou, et al.
ACS Applied Materials & Interfaces
|
July 31, 2024
Unilateral Administration of Surface-Modified G1 and G4 PAMAM Dendrimers in Healthy Mice to Assess Dendrimer Migration in the Brain
Bhairavi Srinageshwar, Cassandra Thompson, Paulina Otero, et al.
Rheumatology (Oxford, England)
|
August 7, 2020
Clonal haematopoiesis is increased in early onset in systemic sclerosis
Laure Ricard, Pierre Hirsch, Laëtitia Largeaud, et al.
Molecules (Basel, Switzerland)
|
October 13, 2021
Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines
John Gallien, Bhairavi Srinageshwar, Kellie Gallo, et al.
European Journal of Haematology
|
January 29, 2021
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapy
Pamela Abdayem, Nathalie Ibrahim, Yolla El Dakdouki, et al.
Stem Cell Research & Therapy
|
May 15, 2015
Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number
Julien Rossignol, Kyle D Fink, Andrew T Crane, et al.
British Journal of Haematology
|
September 10, 2025
Diagnosis, management and the burden of symptoms of mastocytosis from the physician's perspective: A nationwide study
Julien Rossignol, Laurence Bouillet, Cristina Bulai-Livideanu, et al.
RMD Open
|
December 10, 2024
Higher risk profile among patients with TET2-mutated giant cell arteritis: a cluster analysis
Alexis F Guedon, Asmaa Ouafdi, Nabil Belfeki, et al.
Cancer Medicine
|
April 7, 2020
Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas
Khalil Saleh, Jean-Marie Michot, Antoine Schernberg, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 135) with videos related to
Sort By:
Page
of 14
Stem Cell Research & Therapy
|
January 25, 2014
Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis
Kyle D Fink, Julien Rossignol, Andrew T Crane, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 8, 2019
Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS
Richard Lemal, Guillemette Fouquet, Louis Terriou, et al.
ACS Applied Materials & Interfaces
|
July 31, 2024
Unilateral Administration of Surface-Modified G1 and G4 PAMAM Dendrimers in Healthy Mice to Assess Dendrimer Migration in the Brain
Bhairavi Srinageshwar, Cassandra Thompson, Paulina Otero, et al.
Rheumatology (Oxford, England)
|
August 7, 2020
Clonal haematopoiesis is increased in early onset in systemic sclerosis
Laure Ricard, Pierre Hirsch, Laëtitia Largeaud, et al.
Molecules (Basel, Switzerland)
|
October 13, 2021
Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines
John Gallien, Bhairavi Srinageshwar, Kellie Gallo, et al.
European Journal of Haematology
|
January 29, 2021
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapy
Pamela Abdayem, Nathalie Ibrahim, Yolla El Dakdouki, et al.
Stem Cell Research & Therapy
|
May 15, 2015
Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number
Julien Rossignol, Kyle D Fink, Andrew T Crane, et al.
British Journal of Haematology
|
September 10, 2025
Diagnosis, management and the burden of symptoms of mastocytosis from the physician's perspective: A nationwide study
Julien Rossignol, Laurence Bouillet, Cristina Bulai-Livideanu, et al.
RMD Open
|
December 10, 2024
Higher risk profile among patients with TET2-mutated giant cell arteritis: a cluster analysis
Alexis F Guedon, Asmaa Ouafdi, Nabil Belfeki, et al.
Cancer Medicine
|
April 7, 2020
Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas
Khalil Saleh, Jean-Marie Michot, Antoine Schernberg, et al.
Page
of 14